🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 2 study is to be conducted to evaluate the safety, tolerability,...
Status
Completed
Location
Pulmonary Associates, PA
Start Date
2016-05-26
Trial ID
NCT02688647
Treatments Being Tested
This study seeks to determine if administration of the drug belumosudil (KD...
Status
Active Not Recruiting
Location
University of California, Los Angeles
Start Date
2023-07-07
Trial ID
NCT05806749
Treatments Being Tested
This is a single group, Phase 4, single-arm post-marketing study for treatm...
Status
Completed
Location
Investigational Site Number : 1560001
Start Date
2024-12-04
Trial ID
NCT06616415
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, and pha...
Status
Completed
Location
Investigational site
Start Date
2009-09-21
Trial ID
NCT05918627
Treatments Being Tested
The primary objective is to assess the safety and tolerability of 200 mg of...
Status
Completed
Location
UC Irvine Health, Dept of Dermatology
Start Date
2014-04
Trial ID
NCT02106195
Treatments Being Tested
This study was been conducted to evaluate the safety, tolerability, and act...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2016-09-15
Trial ID
NCT02841995
Treatments Being Tested
This randomized, placebo-controlled phase 2 study was seeking to evaluate t...
Status
Terminated
Location
Viable Research Management_Site number 131
Start Date
2019-06-26
Trial ID
NCT03919799
Treatments Being Tested
The purpose of this study is to evaluate safety and pharmacokinetics (PK) e...
Status
Completed
Location
Investigational Site Number: 8400001
Start Date
2022-07-27
Trial ID
NCT05806567
Treatments Being Tested
This was a phase 2, open-label, single-cohort, multicenter trial of belumos...
Status
Terminated
Location
University of California, Los Angeles Medical Center_Site number 104
Start Date
2021-03-03
Trial ID
NCT04680975
Treatments Being Tested
The purpose of this study is to determine the safety, tolerability, and pha...
Status
Completed
Location
Investigational site
Start Date
2014-03-28
Trial ID
NCT05918614
Treatments Being Tested